Live Breaking News & Updates on Biopharma Trading Down|Page 7

Stay updated with breaking news from Biopharma trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Reaffirms "Buy" Rating for Sutro Biopharma (NASDAQ:STRO)

HC Wainwright reissued their buy rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $16.00 target price on the stock. Separately, Wedbush decreased their price target on shares of Sutro Biopharma from $20.00 to $12.00 and set an outperform rating on […] ....

United States , Sutro Biopharma , Board Of Administration Florida Retirement System , Blackrock Inc , Manufacturers Life Insurance Company , Sectoral Asset Management Inc , Sutro Biopharma Inc , Renaissance Technologies , Free Report , Moderate Buy , Biopharma Trading Down , Get Free Report , Asset Management , Florida Retirement System , Sutro Biopharma Daily , Nasdaq Stro , Reiterated Rating , Hc Wainwright ,

Theravance Biopharma (NASDAQ:TBPH) Rating Reiterated by HC Wainwright

Theravance Biopharma (NASDAQ:TBPH) Rating Reiterated by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Richarda Graham , Theravance Biopharma , Theravance Biopharma Inc , Charles Schwab Investment Management Inc , Principal Financial Group Inc , Acadian Asset Management , Vanguard Group Inc , Free Report , Biopharma Trading Down , Financial Group , Asset Management , Schwab Investment Management , Get Free Report , Theravance Biopharma Daily ,

HC Wainwright Reiterates Buy Rating for Vor Biopharma (NYSE:VOR)

HC Wainwright Reiterates Buy Rating for Vor Biopharma (NYSE:VOR)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , America Corp , Denali Advisors , Vor Biopharma Inc , Jump Financial , Vor Biopharma , Get Free Report , Biopharma Trading Down , Jane Street Group , Biopharma Inc , Vor Biopharma Daily ,

HC Wainwright Reaffirms Buy Rating for Arbutus Biopharma (NASDAQ:ABUS)

HC Wainwright reiterated their buy rating on shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) in a report published on Friday, Benzinga reports. They currently have a $6.00 target price on the biopharmaceutical company’s stock. Separately, StockNews.com lowered shares of Arbutus Biopharma from a buy rating to a hold rating in a research note on […] ....

United States , York Mellon Corp , American International Group Inc , Arbutus Biopharma Corporation , Jpmorgan Chase Co , Moneta Group Investment Advisors , Arbutus Biopharma , Free Report , Biopharma Trading Down , New York Mellon Corp , Street Group , Group Investment Advisors , International Group , Get Free Report , Biopharma Corporation , Arbutus Biopharma Daily , Nasdaq Abus , Reiterated Rating , Hc Wainwright ,

Brokerages Set Ambrx Biopharma Inc. (NYSE:AMAM) Target Price at $19.80

Ambrx Biopharma Inc. (NYSE:AMAM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price […] ....

Ambrx Biopharma , Ambrx Biopharma Inc , Ghost Tree Capital , Ambrx Biopharma Company Profile , Farallon Capital Management , Cantor Fitzgerald , Pricet Rowe Associates Inc , Royal Bank , Darwin Global Management Ltd , Get Free Report , Marketbeat Ratings , Global Management , Capital Management , Tree Capital , Pricet Rowe Associates , Biopharma Trading Down , Get Free , Biopharma Inc , Ambrx Biopharma Daily , Nyse Amam ,